The Science Behind Clinically Studied Probiotics & How To Choose The Right One For You

Written by: Sarah Glinski, RD

Updated: February 3rd, 2026

Probiotics continue to be a hot topic, but along with that popularity comes a lot of misinformation. Probiotics, which are beneficial microbes that provide a specific health benefit to humans, have strain-specific benefits. This means that just because a certain probiotic is beneficial for one symptom (such as bloating) doesn’t mean it will also be effective for a different symptom (like antibiotic-associated diarrhea). Probiotics are available in different forms, including capsules, powders, and certain foods, but the health benefits still depend on the specific strain.

When it comes to choosing a probiotic, evidence matters. Clinically studied probiotics are probiotic strains that have been tested in human clinical trials. When choosing a probiotic, it’s important to consider products that use clinically studied strains. This article will teach you the difference between a probiotic species and strain, why strain identity matters, and what to look for when choosing a probiotic.

Why Probiotics Are Not All The Same

Before diving into how to choose a probiotic, there’s some terminology you need to know. Probiotics are named using a hierarchy. First, there’s the genus, which refers to the broader “family” of microbes. Next, there’s the species, which refers to a specific type of microbe within that family. Finally, there’s the strain, which is the exact, genetically unique species with documented health effects.

Here’s how that naming hierarchy looks in practice:

Limosilactobacillus: Genus
Limosilactobacillus reuteri: Genus + Species
Limosilactobacillus reuteri DSM 17938 = Genus + Species + Strain

In some cases, probiotic names also include a subspecies. For example: Bifidobacterium (genus) animalis (species) lactis (subspecies)DN-173 010 (strain).

It’s important to identify probiotics by their strain, because this is how they are researched in clinical studies. Plus, even probiotics of the same species can have very different health effects. For example, while Limosilactobacillus reuteri DSM 17938 can be used to treat functional constipation and infant colic, Limosilactobacillus reuteri ATCC PTA 6475 has evidence for reducing the symptoms of IBS in adults when combined with Limosilactobacillus reuteri DSM 17938.

What “Clinically Studied” Really Means

When it comes to scientific research, there are several different types of studies. Here are some of the most common types:

In vitro studies: In vitro studies (colloquially known as “test tube” studies) are done outside of living organisms to see how cells or microbes behave in a controlled environment. They are often the starting point for clinical research, but because they’re not done in living organisms, it’s difficult to extrapolate the results to humans.
In vivo studies: In vivo studies are done inside living organisms (such as mice) to observe the effects of a treatment in a whole biological system. While they can provide more insight into how probiotics may benefit health than in vitro studies, they should be interpreted cautiously.
Human clinical trials: Human clinical trials test the treatment (such as probiotics) directly in humans. They’re considered the gold standard of evidence for probiotics because they show how probiotics actually work in the real world by providing direct evidence of safety, proper dosing, and whether or not the probiotic delivers the health benefits it claims.

When choosing a probiotic, look for one with strains that’s been studied in human clinical trials. You may need to do a bit of research to confirm this.

What Makes a Clinical Trial High-Quality?

While human clinical trials are the gold standard in probiotic research, they can vary significantly in quality. Here are some factors to look for when evaluating the quality of a clinical trial:

Randomization: People in the study should be randomly assigned to groups to ensure the results aren’t influenced by variables like age, sex, and health status.
Placebo control: A strong clinical trial should compare the probiotic to a placebo (a treatment that looks and is given just like the real treatment, but contains no active ingredient). This is done so the researchers can determine whether the health benefits are due to the product itself, not the placebo effect (when a person experiences real symptom improvement because they believe they’re receiving an effective treatment) or natural changes in symptoms over time.
Blinding: Blinding is the process of ensuring that the researchers and/or the participants are not aware of whether participants are receiving the study drug or the placebo. In a double-blind trial, neither the researchers nor the participants know which one the participants are receiving. This helps reduce bias in study interpretation.
Transparent methodology: A high-quality study will clearly explain how the trial was conducted. This includes factors like how the participants were selected, what outcomes were measured, and how they analyzed the data.
Published results: Study results should be published in a peer-reviewed journal (a scientific publication where experts in the field review the study before it’s published). This adds a layer of quality control and ensures independent experts have reviewed the findings for accuracy, quality, and credibility.
Trial strain/dose: A well-designed clinical trial should evaluate the same strain and dose used in the final product. If more than one strain is included in the product, the study should look at the effects of the product as a whole, not the individual strains.

Clinical evidence matters for consumers because it ensures that the probiotic actually does what it claims. Additionally, it helps match the right strain to specific symptoms or conditions, reducing the risk of overspending on products that haven’t been clinically validated, as well as ensuring that the product is safe.

How to Choose the Right Clinically Studied Probiotic for Your Needs

While many probiotic products make broad health claims like “improves gut health,” the truth is that clinically studied probiotic strains have very specific health benefits. That means that when you’re choosing a probiotic, you need to first identify why you’re taking it. Here are some common reasons a person may choose to take a probiotic:

To improve the symptoms of IBS
To relieve constipation
To prevent antibiotic-associated diarrhea
To treat infant colic
To reduce the risk of respiratory infections
To reduce the risk of oral health issues (like periodontitis or gingivitis)

By identifying your reason for taking the probiotic, you can then consult a resource like the AEProbio Probiotic Chart to find a product that matches your goal.

It’s also important to choose a product that uses the same dose (measured in CFU, or colony-forming units) as the clinical study. This ensures that adequate probiotics are being provided to promote the specific benefit the product is advertised for.

Most clinically studied probiotics show benefits in about two to four weeks, but this can vary depending on the probiotic strain and the condition. It is reasonable to take a probiotic for about one month before evaluating whether or not it is helping your symptoms. If it’s providing a benefit, you can continue taking it, but if you haven’t seen an improvement in your symptoms, you may wish to discontinue the product and try another evidence-based strain. Probiotics aren’t a cure-all, but the right strain can be helpful in certain situations.

How to Shop for Evidence-Based Probiotics

If you’ve decided to invest in an evidence-based probiotic, there are some key elements to pay attention to on the label:

Strain identification: Evidence-based probiotics should include the full strain name, including the alphanumeric identifier. Probiotics that simply list the species may not do what they claim to, as probiotic research is conducted on specific strains.
Health claims: Check whether the health claims are supported by evidence. Do your own research, or use the AEProbio Probiotic Chart, a free tool that provides up-to-date information about probiotics and their health benefits.
Evidence for combined strains: While individual strains may have proven efficacy and safety individually, combining them into one product requires its own clinical evidence, as microorganisms can behave differently when combined.
CFU count: CFU stands for “colony-forming units” and is a way to measure how many active microbes are present in the probiotic supplement. The CFU count should align with what studies looking at that specific probiotic strain used, not a general “best CFU count.” A higher CFU count does not necessarily mean a probiotic is more effective. For example, 100 million CFU may be more effective and better tolerated for a specific condition or symptom than 10 billion CFU without supporting clinical evidence.
Expiry: It’s important to ensure that the CFU count is guaranteed until the expiry date, not at the time of manufacture. This ensures that you are getting an effective dose of the probiotics for the entire time you’re taking them, as the number of viable microbes declines during storage.
Format: Some probiotics come as capsules, while others (such as those intended for infants or children) come as drops, chewables, or powders. Choose a format that works with your lifestyle.
Storage instructions: Some probiotics are sensitive to heat and moisture. If not stored correctly, they may become ineffective before the listed expiry date.
Allergens and additional ingredients: Some probiotics are provided alongside prebiotics (which act as food for the good microbes contained in probiotic supplements). This can be beneficial for some people because it increases their daily fibre intake. However, some prebiotics (such as inulin) are FODMAPs and may worsen symptoms in people with IBS.
Third-party testing: Third-party testing involves an independent lab testing the final product for purity, label accuracy, and potency. While this step is not required, it can be reassuring for consumers. NSF (National Sanitation Foundation) is one of the most well-known independent testing organizations.

Additionally, there are some red flags to watch out for. Be cautious of products with the following red flags:

No strain identification
Vague marketing claims
No published research
Mega CFU claims without strain-specific evidence (more is not necessarily better; what matters is that the product dose matches the dose used in clinical studies)
Products that rely heavily on in vitro data (test tube studies)

Overall, it’s important to choose a probiotic that has evidence for the symptoms you’re trying to address and lists important information such as the strain, CFU count, expiry, and storage instructions.

When to Consult a Healthcare Provider

While probiotics are generally considered safe, there are some situations where medical guidance is necessary:

Infants (especially preterm)
Pregnant or breastfeeding individuals
People with a weakened immune system
People with chronic gastrointestinal conditions (like inflammatory bowel disease or recurrent infections)
People who are malnourished
Elderly individuals

A healthcare provider can help you choose the right strain, ensure it won’t interact with any of your medications, monitor symptoms and side effects, and determine whether a different treatment is needed.

Final Thoughts

Not all probiotics are created equal, and the specific strain matters when it comes to getting real, evidence-backed benefits. Probiotics work best when they’re targeted tools chosen based on solid clinical evidence rather than broad promises.

As you compare probiotic products, read labels carefully, use a resource like Probiotic Chart to choose evidence-based probiotics matched to your specific needs, and talk to a trusted healthcare professional if you’re unsure which probiotic is right for you.

Key Messages

Probiotic benefits are strain-specific
Human clinical trials are essential for ensuring a probiotic does what it claims to do
Probiotics should be chosen based on your specific health goal (e.g., IBS symptom relief, or regularity in those with functional constipation)

References

National Institutes of Health. (2025). Probiotics: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/
Ojetti, V., Ianiro, G., Tortora, A., D’Angelo, G., Di Rienzo, T. A., Bibbò, S., Migneco, A., & Gasbarrini, A. (2014). The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. Journal of Gastrointestinal and Liver Diseases : JGLD, 23(4), 387–391. https://doi.org/10.15403/jgld.2014.1121.234.elr
Sung, V., Hiscock, H., Tang, M. L., Mensah, F. K., Nation, M. L., Satzke, C., Heine, R. G., Stock, A., Barr, R. G., & Wake, M. (2014). Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ (Clinical Research Ed.), 348, g2107. https://doi.org/10.1136/bmj.g2107
Cruchet, S., Hirsch, S., Villa-López, D., Moreno-Portillo, M., Palomo, J. C., Abreu-Abreu, A. T., Abdo-Francis, J. M., Jiménez-Gutiérrez, C., Rojano, M., López-Velázquez, G., & Gutiérrez-Castrellón, P. (2024). Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: A randomized controlled trial. Frontiers in Gastroenterology, 2, 1296048. https://doi.org/10.3389/fgstr.2023.1296048
McFarland, L. V., Evans, C. T., & Goldstein, E. J. C. (2018). Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. Frontiers in medicine, 5, 124. https://doi.org/10.3389/fmed.2018.00124
International Scientific Association for Probiotics and Prebiotics (2022). Deciphering a probiotic label.
Katkowska, M., Garbacz, K., & Kusiak, A. (2021). Probiotics: Should All Patients Take Them? Microorganisms, 9(12), 2620. https://doi.org/10.3390/microorganisms9122620